KRAS and pancreatic neoplasm: Studies with the KRas4B‐derived CaaX‐1 peptide (GLRKRLRKFRNK‐SKTKCVIM) revealed that this peptide altered downstream signaling of Ras proteins in KRas mutant pancreatic cancer cells.